ID: ALA2262184

Max Phase: Preclinical

Molecular Formula: C21H26O3

Molecular Weight: 326.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(C)ccc1OC(=O)C(C)c1ccc(CC(C)C)cc1

Standard InChI:  InChI=1S/C21H26O3/c1-14(2)12-17-7-9-18(10-8-17)16(4)21(22)24-19-11-6-15(3)13-20(19)23-5/h6-11,13-14,16H,12H2,1-5H3

Standard InChI Key:  YKMMXXXNUBVDJY-UHFFFAOYSA-N

Associated Targets(non-human)

Seed lipoxygenase-1 463 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 326.44Molecular Weight (Monoisotopic): 326.1882AlogP: 4.91#Rotatable Bonds: 6
Polar Surface Area: 35.53Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 6.00CX LogD: 6.00
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.56Np Likeness Score: -0.27

References

1. Doulgkeris CM, Siskou IC, Xanthopoulou N, Lagouri V, Kravaritou C, Eleftheriou P, Kourounakis PN, Rekka EA.  (2012)  Compounds against inflammation and oxidative insult as potential agents for neurodegenerative disorders,  21  (9): [10.1007/s00044-011-9726-x]

Source